# Woodward, Inc.: financial statements, quarterly

WWD · Nasdaq · CIK 108312 · [Technology](/sectors/technology.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/wwd.md) · [Financials](/companies/wwd/financials.md) · [Filings](/companies/wwd/filings.md) · [Insiders](/companies/wwd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wwd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [777 d](/filings/0001193125-25-296204.md) | [787](/filings/0000950170-25-013640.md) | [835](/filings/0000950170-25-061634.md) | [848](/filings/0000950170-25-101257.md) | [854 d](/filings/0001193125-25-296204.md) | [773](/filings/0001193125-26-037182.md) | [884](/filings/0001193125-26-195984.md) | [915](/filings/0001193125-26-325790.md) | [995 d](/filings/0001193125-25-296204.md) | [996](/filings/0001193125-26-037182.md) | [1,091](/filings/0001193125-26-195984.md) | [1,110](/filings/0001193125-26-325790.md) |
| Cost of revenue | $m | [588 d](/filings/0001193125-25-296204.md) | [582](/filings/0000950170-25-013640.md) | [601](/filings/0000950170-25-061634.md) | [618](/filings/0000950170-25-101257.md) | [647 d](/filings/0001193125-25-296204.md) | [583](/filings/0001193125-26-037182.md) | [644](/filings/0001193125-26-195984.md) | [666](/filings/0001193125-26-325790.md) | [718 d](/filings/0001193125-25-296204.md) | [704](/filings/0001193125-26-037182.md) | [775](/filings/0001193125-26-195984.md) | [760](/filings/0001193125-26-325790.md) |
| Research and development | $m | [32.1 d](/filings/0001193125-25-296204.md) | [30.8](/filings/0000950170-25-013640.md) | [36.5](/filings/0000950170-25-061634.md) | [38.7](/filings/0000950170-25-101257.md) | [34.7 d](/filings/0001193125-25-296204.md) | [30.2](/filings/0001193125-26-037182.md) | [37.2](/filings/0001193125-26-195984.md) | [41.1](/filings/0001193125-26-325790.md) | [39.0 d](/filings/0001193125-25-296204.md) | [37.8](/filings/0001193125-26-037182.md) | [46.1](/filings/0001193125-26-195984.md) | [49.3](/filings/0001193125-26-325790.md) |
| Selling, general and administrative | $m | [65.9 d](/filings/0001193125-25-296204.md) | [74.5](/filings/0000950170-25-013640.md) | [81.4](/filings/0000950170-25-061634.md) | [73.8](/filings/0000950170-25-101257.md) | [77.7 d](/filings/0001193125-25-296204.md) | [69.7](/filings/0001193125-26-037182.md) | [83.8](/filings/0001193125-26-195984.md) | [88.7](/filings/0001193125-26-325790.md) | [87.6 d](/filings/0001193125-25-296204.md) | [95.0](/filings/0001193125-26-037182.md) | [102](/filings/0001193125-26-195984.md) | [106](/filings/0001193125-26-325790.md) |
| Interest expense | $m | [11.7 d](/filings/0001193125-25-296204.md) | [11.4](/filings/0000950170-25-013640.md) | [11.5](/filings/0000950170-25-061634.md) | [11.5](/filings/0000950170-25-101257.md) | [13.5 d](/filings/0001193125-25-296204.md) | [12.3](/filings/0001193125-26-037182.md) | [11.9](/filings/0001193125-26-195984.md) | [11.2](/filings/0001193125-26-325790.md) | [10.2 d](/filings/0001193125-25-296204.md) | [10.3](/filings/0001193125-26-037182.md) | [12.0](/filings/0001193125-26-195984.md) | [14.8](/filings/0001193125-26-325790.md) |
| Income tax | $m | [15.4 d](/filings/0001193125-25-296204.md) | [19.7](/filings/0000950170-25-013640.md) | [23.1](/filings/0000950170-25-061634.md) | [20.0](/filings/0000950170-25-101257.md) | [18.2 d](/filings/0001193125-25-296204.md) | [14.8](/filings/0001193125-26-037182.md) | [24.0](/filings/0001193125-26-195984.md) | [18.4](/filings/0001193125-26-325790.md) | [22.1 d](/filings/0001193125-25-296204.md) | [35.4](/filings/0001193125-26-037182.md) | [33.4](/filings/0001193125-26-195984.md) | [46.8](/filings/0001193125-26-325790.md) |
| Net income | $m | [82.7 d](/filings/0001193125-25-296204.md) | [90.0](/filings/0000950170-25-013640.md) | [97.6](/filings/0000950170-25-061634.md) | [102](/filings/0000950170-25-101257.md) | [83.3 d](/filings/0001193125-25-296204.md) | [87.1](/filings/0001193125-26-037182.md) | [109](/filings/0001193125-26-195984.md) | [108](/filings/0001193125-26-325790.md) | [138 d](/filings/0001193125-25-296204.md) | [134](/filings/0001193125-26-037182.md) | [134](/filings/0001193125-26-195984.md) | [147](/filings/0001193125-26-325790.md) |
| Diluted EPS | $ per share | not reported | [1.46](/filings/0000950170-25-013640.md) | [1.56](/filings/0000950170-25-061634.md) | [1.63](/filings/0000950170-25-101257.md) | not reported | [1.42](/filings/0001193125-26-037182.md) | [1.78](/filings/0001193125-26-195984.md) | [1.76](/filings/0001193125-26-325790.md) | not reported | [2.17](/filings/0001193125-26-037182.md) | [2.19](/filings/0001193125-26-195984.md) | [2.40](/filings/0001193125-26-325790.md) |
| Basic EPS | $ per share | not reported | [1.50](/filings/0000950170-25-013640.md) | [1.61](/filings/0000950170-25-061634.md) | [1.69](/filings/0000950170-25-101257.md) | not reported | [1.47](/filings/0001193125-26-037182.md) | [1.83](/filings/0001193125-26-195984.md) | [1.82](/filings/0001193125-26-325790.md) | not reported | [2.23](/filings/0001193125-26-037182.md) | [2.25](/filings/0001193125-26-195984.md) | [2.47](/filings/0001193125-26-325790.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [137](/filings/0000950170-24-130891.md) | [144](/filings/0000950170-24-010257.md) | [317](/filings/0000950170-24-052720.md) | [308](/filings/0000950170-24-089765.md) | [282](/filings/0001193125-25-296204.md) | [284](/filings/0000950170-25-013640.md) | [364](/filings/0000950170-25-061634.md) | [473](/filings/0000950170-25-101257.md) | [327](/filings/0001193125-26-325790.md) | [454](/filings/0001193125-26-037182.md) | [501](/filings/0001193125-26-195984.md) | [475](/filings/0001193125-26-325790.md) |
| Current assets | $m | [1,469](/filings/0000950170-24-130891.md) | [1,546](/filings/0000950170-24-010257.md) | [1,812](/filings/0000950170-24-052720.md) | [1,788](/filings/0000950170-24-089765.md) | [1,744](/filings/0001193125-25-296204.md) | [1,725](/filings/0000950170-25-013640.md) | [1,912](/filings/0000950170-25-061634.md) | [2,061](/filings/0000950170-25-101257.md) | [1,884](/filings/0001193125-26-325790.md) | [2,049](/filings/0001193125-26-037182.md) | [2,272](/filings/0001193125-26-195984.md) | [2,339](/filings/0001193125-26-325790.md) |
| Total assets | $m | [4,010](/filings/0001193125-25-296204.md) | [4,131](/filings/0000950170-24-010257.md) | [4,366](/filings/0000950170-24-052720.md) | [4,320](/filings/0000950170-24-089765.md) | [4,369](/filings/0001193125-25-296204.md) | [4,281](/filings/0000950170-25-013640.md) | [4,493](/filings/0000950170-25-061634.md) | [4,712](/filings/0000950170-25-101257.md) | [4,630](/filings/0001193125-26-325790.md) | [4,734](/filings/0001193125-26-037182.md) | [4,969](/filings/0001193125-26-195984.md) | [5,196](/filings/0001193125-26-325790.md) |
| Current liabilities | $m | [617](/filings/0000950170-24-130891.md) | [583](/filings/0000950170-24-010257.md) | [692](/filings/0000950170-24-052720.md) | [913](/filings/0000950170-24-089765.md) | [924](/filings/0001193125-25-296204.md) | [915](/filings/0000950170-25-013640.md) | [980](/filings/0000950170-25-061634.md) | [1,010](/filings/0000950170-25-101257.md) | [907](/filings/0001193125-26-325790.md) | [999](/filings/0001193125-26-037182.md) | [1,312](/filings/0001193125-26-195984.md) | [1,421](/filings/0001193125-26-325790.md) |
| Total liabilities | $m | [1,939](/filings/0000950170-24-130891.md) | [1,941](/filings/0000950170-24-010257.md) | [2,037](/filings/0000950170-24-052720.md) | [2,161](/filings/0000950170-24-089765.md) | [2,192](/filings/0001193125-25-296204.md) | [2,073](/filings/0000950170-25-013640.md) | [2,156](/filings/0000950170-25-061634.md) | [2,243](/filings/0000950170-25-101257.md) | [2,064](/filings/0001193125-26-325790.md) | [2,146](/filings/0001193125-26-037182.md) | [2,444](/filings/0001193125-26-195984.md) | [2,723](/filings/0001193125-26-325790.md) |
| Long-term debt | $m | [646](/filings/0000950170-24-130891.md) | [653](/filings/0000950170-24-010257.md) | [649](/filings/0000950170-24-052720.md) | [563](/filings/0000950170-24-089765.md) | [570](/filings/0001193125-25-296204.md) | [483](/filings/0000950170-25-013640.md) | [490](/filings/0000950170-25-061634.md) | [504](/filings/0000950170-25-101257.md) | [457](/filings/0001193125-26-325790.md) | [457](/filings/0001193125-26-037182.md) | [453](/filings/0001193125-26-195984.md) | [618](/filings/0001193125-26-325790.md) |
| Current portion of debt | $m | [75.8](/filings/0000950170-24-130891.md) | [0.7](/filings/0000950170-24-010257.md) | [0.7](/filings/0000950170-24-052720.md) | [85.7](/filings/0000950170-24-089765.md) | [85.7](/filings/0001193125-25-296204.md) | [161](/filings/0000950170-25-013640.md) | [161](/filings/0000950170-25-061634.md) | [76.0](/filings/0000950170-25-101257.md) | [123](/filings/0001193125-26-325790.md) | [48.0](/filings/0001193125-26-037182.md) | [46.9](/filings/0001193125-26-195984.md) | [132](/filings/0001193125-26-325790.md) |
| Short-term borrowings | $m | [0.0](/filings/0000950170-24-130891.md) | [65.1](/filings/0000950170-24-010257.md) | [141](/filings/0000950170-24-052720.md) | [275](/filings/0000950170-24-089765.md) | [217](/filings/0001193125-25-296204.md) | [258](/filings/0000950170-25-013640.md) | [261](/filings/0000950170-25-061634.md) | [353](/filings/0000950170-25-101257.md) | [122](/filings/0001193125-26-325790.md) | [383](/filings/0001193125-26-037182.md) | [623](/filings/0001193125-26-195984.md) | [592](/filings/0001193125-26-325790.md) |
| Shareholders' equity | $m | [2,071](/filings/0001193125-25-296204.md) | [2,190](/filings/0000950170-25-061634.md) | [2,329](/filings/0000950170-25-101257.md) | [2,159](/filings/0000950170-25-101257.md) | [2,176](/filings/0001193125-26-325790.md) | [2,208](/filings/0001193125-26-195984.md) | [2,338](/filings/0001193125-26-325790.md) | [2,469](/filings/0001193125-26-325790.md) | [2,566](/filings/0001193125-26-325790.md) | [2,587](/filings/0001193125-26-195984.md) | [2,525](/filings/0001193125-26-195984.md) | [2,474](/filings/0001193125-26-325790.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [153 d](/filings/0001193125-25-296204.md) | [46.8](/filings/0000950170-25-013640.md) | [97.3 d](/filings/0000950170-25-061634.md) | [153 d](/filings/0000950170-25-101257.md) | [142 d](/filings/0001193125-25-296204.md) | [34.5](/filings/0001193125-26-037182.md) | [77.8 d](/filings/0001193125-26-195984.md) | [126 d](/filings/0001193125-26-325790.md) | [233 d](/filings/0001193125-25-296204.md) | [114](/filings/0001193125-26-037182.md) | [90.8 d](/filings/0001193125-26-195984.md) | [147 d](/filings/0001193125-26-325790.md) |
| Capital expenditure | $m | [19.4 d](/filings/0001193125-25-296204.md) | [41.8](/filings/0000950170-25-013640.md) | [14.5 d](/filings/0000950170-25-061634.md) | [15.9 d](/filings/0000950170-25-101257.md) | [24.1 d](/filings/0001193125-25-296204.md) | [33.6](/filings/0001193125-26-037182.md) | [18.4 d](/filings/0001193125-26-195984.md) | [26.5 d](/filings/0001193125-26-325790.md) | [52.4 d](/filings/0001193125-25-296204.md) | [44.1](/filings/0001193125-26-037182.md) | [52.6 d](/filings/0001193125-26-195984.md) | [59.6 d](/filings/0001193125-26-325790.md) |
| Share repurchases | $m | [100 d](/filings/0001193125-25-296204.md) | not reported | not reported | not reported | [86.0 d](/filings/0001193125-25-296204.md) | [35.5](/filings/0001193125-26-037182.md) | [44.0 d](/filings/0001193125-26-195984.md) | [44.8 d](/filings/0001193125-26-325790.md) | [48.6 d](/filings/0001193125-25-296204.md) | [129](/filings/0001193125-26-037182.md) | [226 d](/filings/0001193125-26-195984.md) | [198 d](/filings/0001193125-26-325790.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) | Q3 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [60.9](/filings/0000950170-24-010257.md) | [61.2](/filings/0000950170-24-052720.md) | [61.6](/filings/0000950170-24-089765.md) | [61.8](/filings/0000950170-25-013640.md) | [62.4](/filings/0000950170-25-061634.md) | [62.5](/filings/0000950170-25-101257.md) | [61.1](/filings/0001193125-26-037182.md) | [61.3](/filings/0001193125-26-195984.md) | [61.5](/filings/0001193125-26-325790.md) | [61.6](/filings/0001193125-26-037182.md) | [61.3](/filings/0001193125-26-195984.md) | [61.0](/filings/0001193125-26-325790.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 59,045,820 at 2026-07-28, from the cover of the [10-Q filed 2026-07-30](/filings/0001193125-26-325790.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.